AQXP - Aquinox Pharmaceuticals, Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AQXP (1404644)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
14 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P10+2+6-4-22
S4-4-15-18-53

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-01-09
AQXPBaker Bros. Advisors LP10%P - Purchase$17.18+398,0629,768,979+4%+$6,836,813+1+1+6
2016-09-20
AQXPBaker Bros. Advisors LP10%P - Purchase$12.25+2,783,6051,136,145-169%+$34,110,452+10+6-24+11
M
2016-03-15
AQXPBaker Bros. Advisors LP10%P - Purchase$7.99+471,6677,714,060+7%+$3,770,636-2+6+16+49
M
2016-01-22
AQXPBaker Bros. Advisors LP10%P - Purchase$10.80+140,7867,273,273+2%+$1,520,909+1+14-10-29
M
2016-01-19
AQXPBaker Bros. Advisors LP10%P - Purchase$9.33+190,0797,130,815+3%+$1,773,653+7+11+1-27
AM
2016-01-14
AQXPBaker Bros. Advisors LP10%P - Purchase$8.28+202,6236,944,348+3%+$1,677,0830+22+10-22
M
2016-01-14
AQXPBaker Bros. Advisors LP10%P - Purchase$8.28+202,6236,944,348+3%+$1,677,0830+22+10-22
2015-09-10
AQXPBaker Bros. Advisors LP10%P - Purchase$15.50+2,480,0326,751,852+58%+$38,440,496+2+4-26-56
2015-08-24
AQXPMitchell David ChiltonVP Global Regulatory, QualityP - Purchase$17.81+3,5755,175+223%+$63,671-5-90-44
D
2015-08-12
AQXPMackenzie LloydVP Technical OperationsS - Sale+OE$18.67-35,8870-100%-$670,010-7-24-23-61
D
2015-08-12
AQXPAlam KamranCFO, VP FinanceS - Sale+OE$18.67-29,0790-100%-$542,905-7-24-23-61
2015-08-11
AQXPMitchell David ChiltonVP Global Regulatory, QualityP - Purchase$24.36+1,6001,600New+$38,976+8-18-18-62
2015-08-10
AQXPPfizer Inc10%S - Sale$26.47-259,927975,403-21%-$6,880,295+16+3-5-37
M
2015-08-10
AQXPJohnson & Johnson10%S - Sale$22.41-1,514,821100,000-94%-$33,944,876-17-14-22-54

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top